A retrospective study published in Frontiers in Cellular and Infection Microbiology reveals that antibiotic-associated diarrhea (AAD) manifests in two distinct microbial profiles, depending on the presence or absence of Clostridioides difficile. While both conditions share a significant reduction in overall gut microbial diversity, they are characterized by unique taxonomic signatures at the species level. The research, conducted by a team from Inje University in South Korea, analyzed stool samples from 42 hospitalized patients and 21 healthy controls to differentiate the microbiome profiles of C. difficile-positive (CDAD) and C. difficile-negative (non-CDAD) AAD.
The study aimed to address a gap in clinical understanding, as C. difficile is the most widely recognized cause of AAD, yet a substantial proportion of cases are not attributable to this pathogen. Many patients develop diarrhea following antibiotic therapy without detectable C. difficile, suggesting heterogeneous underlying mechanisms involving antibiotic-induced dysbiosis and the expansion of other opportunistic pathogens. By comparing these two groups against healthy controls, the researchers sought to identify specific microbial markers that could help distinguish between the two forms of antibiotic-associated diarrhea.
The investigation utilized 16S rRNA gene-based microbiome analysis to profile the gut communities. Stool specimens were collected from patients admitted to Inje University Busan Paik Hospital who experienced three or more episodes of diarrhea per day following antibiotic treatment. The patients were classified into the CDAD group (19 individuals) and the non-CDAD group (23 individuals) based on real-time PCR results targeting the toxin B gene. To minimize technical bias, the healthy control cohort consisted of 21 Korean adults whose microbiome data were generated using the same sequencing platform, primer set, and bioinformatics pipeline as the patient samples.
Alpha diversity analysis demonstrated that both the CDAD and non-CDAD groups exhibited significantly reduced microbial richness and diversity compared with the healthy controls. All measured indices, including ACE, Chao1, and the Shannon index, showed significant differences among the three groups, with the healthy group consistently exhibiting the highest levels of microbial diversity. However, no significant differences in alpha diversity were observed between the two AAD groups, suggesting that the overall extent of microbial disruption is comparable regardless of C. difficile detection.
Beta diversity analysis further confirmed that both AAD groups clustered distinctly from the healthy controls but did not differ significantly from each other. This indicates that while antibiotic exposure profoundly alters the overall microbial community structure in both conditions, the specific composition of the microbiota diverges based on the presence of C. difficile. The depletion of short-chain fatty acid-producing genera, such as Faecalibacterium, Roseburia, and Agathobacter, was a common feature in both AAD groups, highlighting a shared loss of beneficial commensal bacteria associated with intestinal homeostasis.
Despite the similar reduction in diversity, linear discriminant analysis effect size (LEfSe) identified distinct species-level discriminatory taxa for each group. The non-CDAD group was characterized by an enrichment of the Enterococcus faecium group, Enterococcus faecalis, the Enterobacteriaceae group, Klebsiella sp. FWNZ, and Alistipes onderdonkii. In contrast, the CDAD group showed enrichment of the C. difficile group, Bifidobacterium scardovii, Bacteroides thetaiotaomicron, Ruminococcus gnavus, Clostridium ramosum, and Flavonifractor plautii. These findings suggest that CDAD and non-CDAD represent distinct forms of antibiotic-induced intestinal dysbiosis with unique microbial signatures.
The expansion of enterococci and Enterobacteriaceae in the non-CDAD group is a well-recognized feature of antibiotic-perturbed intestinal communities. Antibiotic-mediated disruption reduces colonization resistance, creating ecological conditions that favor the expansion of opportunistic taxa. However, the researchers emphasized that these taxonomic differences represent associations with the respective clinical groups and do not establish causal or mechanistic roles for the enriched taxa in the development of AAD. The specific association of Alistipes onderdonkii with C. difficile-negative AAD had not been well characterized in previous literature, identifying it as a potential candidate for a microbial signature.
An additional notable finding was the incomplete concordance between target-specific PCR and 16S rRNA gene-based microbiome analysis for the detection of C. difficile. Although C. difficile was detected by 16S rRNA gene-based analysis in 94.7% of patients with CDAD when any detectable reads were considered positive, one PCR-positive specimen had no detectable C. difficile reads. This discrepancy likely reflects methodological differences, as targeted PCR can detect low bacterial loads, whereas 16S rRNA gene-based analysis profiles the entire community and may miss organisms that constitute a very small proportion of the total sequencing reads.
The study also observed low-level detection of C. difficile in individuals without CDAD. In the non-CDAD group, C. difficile was detected at very low relative abundances in three patients. These findings demonstrate overlap in low-level C. difficile detection between patients with and without CDAD, suggesting that relative abundance alone cannot reliably distinguish between these groups. Furthermore, 16S rRNA gene-based analysis cannot distinguish toxigenic from nontoxigenic strains or determine whether toxin production is occurring, meaning it should not be interpreted as an alternative to established diagnostic testing.
The researchers acknowledged several limitations, including the relatively small sample size and the single-center retrospective design, which may have limited statistical power and prevented independent validation in an external cohort. The use of 16S rRNA gene-based analysis also limits functional interpretation, as microbial metabolic activity cannot be directly inferred from taxonomic profiles alone. Additionally, detailed clinical information regarding antibiotic exposure and treatment status was not available, meaning the potential effects of these factors on the observed microbiome differences could not be assessed.
In conclusion, the study provides further insights into the microbial ecology of antibiotic-associated diarrhea, identifying that while overall diversity is similarly reduced in both C. difficile-positive and negative cases, distinct taxonomic signatures exist. These findings highlight the complexity of antibiotic-induced dysbiosis and identify candidate microbial signatures that warrant further validation in independent cohorts. The research underscores the need for complementary approaches to understand the mechanisms underlying intestinal microbiome recovery and the specific roles of various taxa in AAD.
Methodological details from the investigation highlight the technical steps used to generate bacterial profiles from stool specimens. Genomic DNA was isolated using specialized extraction kits, after which the hypervariable V3 to V4 region of the 16S rRNA gene was amplified with universal primers 341F and 805R alongside fusion polymerase. Sequencing was performed on an Illumina MiSeq instrument using paired-end chemistry. After quality filtering, primer trimming, denoising, and chimera removal, taxonomic assignments were completed using the EzBioCloud platform against a curated ribosomal reference database. Across all processed samples, sequencing yielded a mean depth of 40.4 million bases per specimen, spanning from 29.6 million to 61.6 million bases. Taxa designated under group labels represented tightly clustered reference sequences that could not be completely resolved to individual species using short-amplicon profiling alone.
Multivariate statistical evaluations provided precise quantitative boundaries for community separation between cohorts. Bray-Curtis distance testing via PERMANOVA demonstrated marked structural divergence between the healthy control group and both diarrhea cohorts, registering a pseudo-F of 17.082 and an effect size R-squared of 0.310 when compared with C. difficile-positive patients, and a pseudo-F of 17.793 with an R-squared of 0.298 when compared with C. difficile-negative patients. Conversely, direct community differentiation between the two diarrhea groups remained non-significant, yielding a pseudo-F of 1.519, an R-squared of 0.037, and an adjusted q-value of 0.075. Complementary tests of multivariate dispersion revealed significant variation between healthy individuals and both patient cohorts, indicating that community separations involving healthy donors were influenced by within-group dispersion differences. Furthermore, direct pairwise differential testing between the two diarrhea cohorts demonstrated that the C. difficile group was the sole species-level taxon retaining statistical significance following false discovery rate adjustment, recording an LDA score of 3.733 alongside an adjusted P value of 0.00012.
A granular assessment of relative microbial abundances uncovered pronounced genus-level reconfigurations across all three cohorts. In C. difficile-positive patients, Enterococcus constituted 20.6 percent of total community abundance, followed by Bacteroides at 17.8 percent, Escherichia at 8.6 percent, Akkermansia at 5.1 percent, and Parabacteroides at 4.5 percent. In the C. difficile-negative cohort, Enterococcus was even more dominant at 37.1 percent, accompanied by an Enterobacteriaceae cluster at 7.3 percent, Klebsiella at 6.8 percent, Lactobacillus at 6.3 percent, and Escherichia at 6.0 percent. In contrast, healthy controls were dominated by Prevotella at 22.4 percent, Faecalibacterium at 10.0 percent, Blautia at 8.7 percent, and Agathobacter at 4.1 percent. At the species level, the Enterococcus faecium group comprised 17.3 percent of the C. difficile-positive flora and 29.6 percent of the negative flora, while Akkermansia muciniphila reached 4.9 percent in the positive group. In healthy donors, Prevotella reference strain PAC001304 made up 14.4 percent, while the Faecalibacterium prausnitzii cluster accounted for 9.8 percent.
Descriptive threshold modeling provided further insight into the diagnostic dynamics of low-abundance sequence reads. When specific descriptive thresholds were imposed on C. difficile-positive specimens, detection dropped from 94.7 percent without cutoffs to 78.9 percent at a 0.01 percent relative abundance threshold, and to 63.2 percent at a 0.1 percent threshold, with patient-wide median abundance measuring 0.270 percent. Among the three C. difficile-negative samples displaying trace reads, observed proportions were 0.0037 percent, 0.0096 percent, and 0.0148 percent, meaning only one non-CDAD sample remained positive at 0.01 percent, and none satisfied 0.1 percent. This technical nuance aligns with broader epidemiological patterns, where antibiotic therapy triggers diarrhea in 5 to 35 percent of patients, particularly following exposure to agents like clindamycin, cephalosporins, penicillins, or fluoroquinolones. Because C. difficile accounts for only 20 to 30 percent of these diarrheal episodes, microbial depletion itself, rather than isolated pathogen invasion, drives the clinical syndrome.
Subject of Research: Gut microbiome profiles in Clostridioides difficile-positive and C. difficile-negative antibiotic-associated diarrhea
Article Title: Gut microbiome profiles in Clostridioides difficile-positive and C. difficile-negative antibiotic-associated diarrhea
Article References: Kim, E.-Y., Kim, S. M., Kim, S. H., & Shin, J. H. (2026). Gut microbiome profiles in Clostridioides difficile-positive and C. difficile-negative antibiotic-associated diarrhea. Frontiers in Cellular and Infection Microbiology, 16, 1983607. https://doi.org/10.3389/fcimb.2026.1983607
Image Credits: AI Generated
DOI: 10.3389/fcimb.2026.1983607
Keywords: gut microbiome, antibiotic-associated diarrhea, Clostridioides difficile, microbial dysbiosis, 16S rRNA sequencing, Enterococcus, Klebsiella, clinical microbiology, retrospective study, microbiome, profiles, Clostridioides
News Source: Morgan Morrow. (November 10, 2026). Distinct Gut Microbiome Signatures Identified in Two Diarrhea Types. Scienmag.



